← Leaderboards
Juliette Elizabeth McGregor
University Of Rochester
$5,749,511
Attributed
$5,765,511
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,765,511 · 2
By mechanism
U24$5,733,511 · 1
R13$32,000 · 1
Top collaborators
- Manuel Gomez-Ramirez1 shared
Most similar at University Of Rochester
Same institution · by research overlap
- Joseph Carroll$17,281,412
- David R Williams$29,040,923
- Jennifer J Hunter$6,436,188
- Krystel R Huxlin$15,462,188
- William H Merigan$11,100,062
Others in their field
Other Emerging Leaders on “Vision”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$77,392,336
- Dwayne Forquer · Leidos Biomedical Research, Inc.$50,844,487
- Laura Ferrarese · Association Of Universities For Research In Astronomy, Inc.$47,742,424
- Anthony Philippakis · University Of California Santa Cruz$41,478,771
Research focus
VisionImaging ApproachPreclinical TestingTherapy DevelopmentCalciumCollaborationsIn VivoOpticsRodentTechnologySuccessSignal TransductionResolutionIn Vivo ImagingImageClinical TrialsConeFundingCellular ImagingCustomDensityFutureAnatomyCalifornia
Grant awards (7)
Accelerating photoreceptor replacement therapy with in-vivo cellular imaging of retinal function$850,404
U24 · FY2025 · EY · contact PI
Accelerating photoreceptor replacement therapy with in-vivo cellular imaging of retinal function$1,154,491
U24 · FY2024 · EY · contact PI
Symposium on imaging and modulation of neural activity in vivo: From the Eye to the Brain$32,000
R13 · FY2024 · EY · contact PI
Accelerating photoreceptor replacement therapy with in-vivo cellular imaging of retinal function$1,171,199
U24 · FY2023 · EY · contact PI
Supplement to Accelerating photoreceptor replacement therapy with in-vivo cellular imaging of retinal function$165,783
U24 · FY2023 · EY · contact PI
Accelerating photoreceptor replacement therapy with in-vivo cellular imaging of retinal function$1,158,449
U24 · FY2022 · EY · contact PI
Accelerating photoreceptor replacement therapy with in-vivo cellular imaging of retinal function$1,233,185
U24 · FY2021 · EY · contact PI